Shiba Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.20 M
as on 29-12-2024
- Paid Up Capital ₹ 1.10 M
as on 29-12-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.70 M
as on 29-12-2024
- Revenue -7.66%
(FY 2020)
- Profit 135.02%
(FY 2020)
- Ebitda 34.20%
(FY 2020)
- Net Worth 307.32%
(FY 2020)
- Total Assets 11.64%
(FY 2020)
About Shiba Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.20 M and a paid-up capital of Rs 1.10 M.
The company currently has active open charges totaling ₹5.70 M.
Kusum Singh and Rajesh Singh serve as directors at the Company.
- CIN/LLPIN
U24232UP2004PTC028949
- Company No.
028949
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
16 Aug 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Kanpur
Industry
Company Details
- Location
Lucknow, Uttar Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Shiba Life Sciences?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Kusum Singh  | Director | 16-Apr-2007 | Current |
| Rajesh Singh | Director | 26-Nov-2008 | Current |
Financial Performance of Shiba Life Sciences.
Shiba Life Sciences Private Limited, for the financial year ended 2020, experienced Minor drop in revenue, with a 7.66% decrease. The company also saw a substantial improvement in profitability, with a 135.02% increase in profit. The company's net worth Soared by an impressive increase of 307.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shiba Life Sciences?
In 2020, Shiba Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Strong Medicine Labs Private LimitedActive 3 years 7 monthsKusum Singh and Rajesh Singh are mutual person
Charges (Loans)
₹5.70 M
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.53 Cr
- Others : 0.04 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 11 Aug 2021 | Others | ₹0.40 M | Open |
| 29 Dec 2009 | Canara Bank | ₹5.30 M | Open |
How Many Employees Work at Shiba Life Sciences?
Unlock and access historical data on people associated with Shiba Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shiba Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shiba Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
